Midatech: Surges on positive pipeline and operational updates
17/06/2021 12:46
** U.S.-listed shares of drug developer MTP.O surge 47% to
$3.07 premarket
** Co says in vitro data shows its technology Q-Sphera can
formulate proteins into long-acting injectable products urn:newsml:reuters.com:*:nACSLWp5qa
** MTP has also shut down its Bilbao operations, thus
halving its monthly cash burn rate
** Also shifts focus to expanded pipeline of nine
early-stage programmes from singular focus on late-stage ready
asset MTD201
** Stock up 9.1% YTD
(Reporting by Trisha Roy in Bengaluru)
((Trisha.Roy@thomsonreuters.com; within U.S. +1 646 223 8780,
outside U.S. +91 80 6182 3635;))